Friday, November 6, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

MicroStrategy’s Bitcoin Bet Intensifies as Index Exclusion Looms

Robert Sasse by Robert Sasse
September 15, 2025
in Analysis, Bitcoin, Crypto Stocks, S&P 500
0
Strategy Stock
0
SHARES
194
VIEWS
Share on FacebookShare on Twitter

MicroStrategy continues to double down on its monumental cryptocurrency position, reinforcing its status as the world’s largest corporate holder of Bitcoin. However, this aggressive accumulation strategy comes at a cost, as the company faces continued exclusion from the prestigious S&P 500 index despite meeting formal eligibility requirements.

Persistent Bitcoin Acquisition

The business intelligence firm executed another significant purchase between September 2nd and 7th, acquiring 1,955 Bitcoin at a total cost of $217.4 million. This latest investment brought the average purchase price to approximately $111,196 per coin.

MicroStrategy’s treasury now holds an unprecedented 638,460 Bitcoin, valued at roughly $71 billion at current market prices. The company’s total investment in cryptocurrency amounts to approximately $47.2 billion, reflecting an average acquisition cost of $73,880 per Bitcoin. These recent purchases were funded through the sale of corporate stock and convertible notes.

Index Committee Rejection

In a move that surprised market observers, the S&P 500 index committee declined to include MicroStrategy in its benchmark index during the September rebalancing period. This decision came despite the company meeting the necessary market capitalization thresholds and reporting positive quarterly earnings.

The exclusion appears rooted in concerns over the extreme volatility of MicroStrategy’s earnings, which directly correlate with Bitcoin price fluctuations. The S&P 500 traditionally favors companies with diversified revenue streams and stable financial performance. This rejection denies MicroStrategy access to substantial passive investment flows from index funds and ETFs that automatically track the benchmark index.

Should investors sell immediately? Or is it worth buying Strategy?

Leadership Defends Strategy

Executive Chairman Michael Saylor remains undeterred, presenting compelling performance metrics to justify the company’s approach. According to Saylor, MicroStrategy’s Bitcoin strategy has generated an annualized return of 91 percent, significantly outperforming notable tech giants. By comparison, Nvidia has achieved 72 percent while Tesla posted 32 percent over the same period.

With capital costs of 14 percent and Bitcoin returns of 55 percent, the company’s leadership maintains that their mathematical model supports continued accumulation.

Technical Pressures Mount

Despite impressive theoretical returns, MicroStrategy shares face significant technical headwinds. The stock currently trades below key technical indicators and maintains a clear downward trajectory.

Equity researchers at TD Cowen maintained their “Buy” recommendation but reduced their price target from $680 to $640, acknowledging the persistent volatility concerns. The company’s extreme concentration in Bitcoin remains the primary risk factor for investors considering the stock.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from November 5 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 5.

Strategy: Buy or sell? Read more here...

Tags: Strategy
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Münchener Rück Stock
Analysis

Munich Re’s Monte Carlo Warning Collides With Wall Street’s Widest Analyst Split in Years

September 7, 2026
Novo Nordisk Stock
Analysis

Novo Nordisk Faces a New Front: 300-Fold Rise in GLP-1 Scripts for Children Under 12

September 7, 2026
Next Post
Bruker Stock

Bruker Faces Investor Backlash After Surprise Equity Offering

Chevron Stock

Chevron Navigates Strategic Overhaul Amid Divergent Investor Views

Enphase Energy Stock

Enphase Energy Faces S&P 500 Removal in Major Index Shakeup

Recommended

indiemiconductor Stock

Indie Semiconductor Shares Face Technical Headwinds

1 year ago
BioNTech Stock

BioNTech Secures CureVac Acquisition in Landmark mRNA Deal

11 months ago
Food Retailers Market Capitalization

Victorias Secret Reports Strong Earnings Growth and Strategic Initiatives for Future Success

3 years ago

CNH Industrials Financial Report for Q4 2023 Meeting Expectations and Predicting a Slowdown in 2024

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

Pharma Pays for the Rotation While Crypto Hunts for a Floor

Tech Loses $1 Trillion, but the Rest of the Market Holds

Alphabet’s Cloud Doubles, Its Cash Turns Negative, the Stock Sinks

Margins Over Stories: Who Delivers Before the Fed and Big Tech

UPS and Coca-Cola Raise Guidance by Charging More, Not Selling More

Trending

Fastly Stock
Newsletter

Maersk Lifts Guidance a Third Time, and the Stock Still Sinks

by Stephanie Dugan
November 5, 2026
0

Dear readers, Raised guidance was supposed to be the safe harbor of earnings season. Maersk has tested...

AMD Stock

Democrats Win, and the Market Sorts Solar From Musk and Defense

November 4, 2026
Apple Stock

Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

November 3, 2026
Lumentum Stock

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

November 2, 2026
Bitcoin Stock

Pharma Pays for the Rotation While Crypto Hunts for a Floor

October 31, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Maersk Lifts Guidance a Third Time, and the Stock Still Sinks
  • Democrats Win, and the Market Sorts Solar From Musk and Defense
  • Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com